Lupus & antiphospholipid syndrome
A qualitative study of facilitators of medication adherence in systemic lupus erythematosus: Perspectives from rheumatology providers/staff and patients
Authors' conclusion
Using an established behavioral change model, we categorized a breadth of adherence facilitators within each domain of the COM-B model while highlighting patients' individual approaches.
Study context
- Population
- Patients with systemic lupus erythematosus (SLE) from racial and ethnic minority groups taking immunosuppressants, and lupus providers and staff
- Outcome
- Factors that enable adherence to immunosuppressive medications
Methodological detailsin-depth interviews, purposeful sampling, applied thematic analysis, Capability, Opportunity, Motivation, Behavior (COM-B) model
- In-depth interviews
- Purposeful sampling
- Applied thematic analysis
- COM-B model
Main finding
As reported in the abstract
Adherence facilitators
- Patients most often described social support, physical well-being, reminders and ability to acquire medications as facilitators
- Providers commonly mentioned reminders, easy medication access, patient education/communication and empowerment as facilitators
- Each patient described a unique set of facilitators
Parts of this Brief are withheld: the automatic checks could not confirm them against the abstract.
Original publication
A qualitative study of facilitators of medication adherence in systemic lupus erythematosus: Perspectives from rheumatology providers/staff and patients. Lupus. Published 2 January 2024. doi:10.
Composed by AI from the published abstract and checked against it. How Briefs are made →